The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence
Abstract
PURPOSE: To review recent advances in the pathophysiology and potential clinical applications of leptin, an adipose tissue-derived hormone. DATA SOURCES: A MEDLINE search of the literature on leptin and the bibliographies of relevant papers. STUDY SELECTION: All 1320 publications on leptin. DATA EXTRACTION: All identified articles were reviewed. Cited publications were selected on the basis of study quality and relevance to human obesity and disease. DATA SYNTHESIS: Leptin is a 16-kilodalton adipocyte-derived hormone that circulates in the serum in the free and bound form. Serum levels of leptin reflect the amount of energy stored in adipose tissue. Short-term energy imbalance as well as serum levels of several cytokines and hormones influence circulating leptin levels. Leptin acts by binding to specific receptors in the hypothalamus to alter the expression of several neuropeptides that regulate neuroendocrine function and energy intake and expenditure. Thus, leptin plays an important role in the pathogenesis of obesity and eating disorders and is thought to mediate the neuroendocrine response to food deprivation. Phase I and II trials recently showed that leptin administration to humans is safe, and ongoing phase III trials are assessing the efficacy of leptin as a treatment for obesity and related disorders. Availability of leptin or smaller and more soluble leptin analogues for clinical studies in humans is expected to significantly advance understanding of the mechanisms underlying energy homeostasis in humans. CONCLUSIONS: Leptin is significantly broadening our understanding of the mechanisms underlying neuroendocrine function, body weight, and energy homeostasis. Elucidation of these mechanisms is expected to result in the development of novel therapeutic approaches for obesity and eating disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Abnormal splicing of the leptin receptor in diabetic mice
Lee, G.-H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., & Friedman, J. M. (1996) · Nature · doi:10.1038/379632a0 · Cited by 2,327
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Frisch, R. E., & McArthur, J. W. (1974) · Science · doi:10.1126/science.185.4155.949 · Cited by 1,412
A leptin missense mutation associated with hypogonadism and morbid obesity
Strobel, A., Issad, T., Camoin, L., Ozata, M., & Strosberg, A. D. (1998) · Nature Genetics · doi:10.1038/ng0398-213 · Cited by 1,158
Jackson, R. S., Creemers, J. W. M., Ohagi, S., Raffin-Sanson, M.-L., Sanders, L., Montague, C. T., Hutton, J. C., & O'Rahilly, S. (1997) · Nature Genetics · doi:10.1038/ng0797-303 · Cited by 1,153
Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans
Schwartz, M. W., Peskind, E., Raskind, M., Boyko, E. J., & Porte, D. (1996) · Nature Medicine · doi:10.1038/nm0596-589 · Cited by 1,014
Identification of SOCS-3 as a Potential Mediator of Central Leptin Resistance
Bjørbæk, C., Elmquist, J. K., Frantz, J. D., Shoelson, S. E., & Flier, J. S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80062-3 · Cited by 1,014
Sarraf, P., Frederich, R. C., Turner, E. M., Ma, G., Jaskowiak, N. T., Rivet, D. J., Flier, J. S., Lowell, B. B., Fraker, D. L., & Alexander, H. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.171 · Cited by 791
Research works printed but not linked: 136
- 10.1007/s001250050838 · DOI
- 10.1074/jbc.271.8.3971 · DOI
- 10.1210/endo.138.2.4908 · DOI
- 10.2337/diab.45.7.984 · DOI · Paper page
- 10.1038/nm0997-1029 · DOI · Paper page
- 10.1038/387206a0 · DOI · Paper page
- 10.1016/0014-5793(95)00977-H · DOI · Paper page
- 10.1038/nm0995-950 · DOI · Paper page
- 10.1056/NEJM199602013340503 · DOI · Paper page
- 10.2337/diab.46.3.342 · DOI · Paper page
- 10.1172/JCI119422 · DOI
- 10.1172/JCI117758 · DOI · Paper page
- 10.7326/0003-4819-126-1-199701010-00004 · DOI
- 10.1073/pnas.94.9.4242 · DOI
- 10.2337/diab.45.11.1511 · DOI · Paper page
- Kolaczynski JW, 1996, J Clin Endocrinol Metab, 81, 4162
- 10.1007/s001250050686 · DOI
- 10.1080/07315724.1998.10718758 · DOI
- 10.2337/diab.45.11.1455 · DOI · Paper page
- 10.1016/0014-5793(95)01485-3 · DOI · Paper page
- 10.2337/diab.45.10.1435 · DOI · Paper page
- 10.2337/diab.45.10.1364 · DOI
- Ryan AS, 1996, J Clin Endocrinol Metab, 81, 4433
- 10.1007/BF00403921 · DOI
- 10.1016/S0014-5793(96)01477-9 · DOI
- 10.1038/sj.ijo.0800419 · DOI
- 10.1002/j.1550-8528.1998.tb00335.x · DOI
- Donahoo WT, 1997, J Clin Endocrinol Metab, 82, 4139
- 10.2337/diab.45.7.909 · DOI · Paper page
- Mantzoros CS, 1997, J Clin Endocrinol Metab, 82, 2856
- 10.1074/jbc.271.10.5301 · DOI · Paper page
- 10.1055/s-2007-979882 · DOI
- Larsson H, 1996, J Clin Endocrinol Metab, 81, 4428
- Masuzaki H, 1997, J Clin Endocrinol Metab, 82, 2542
- Cizza G, 1997, J Clin Endocrinol Metab, 82, 2747
- Mantzoros CS, 1997, J Clin Endocrinol Metab, 82, 3408
- 10.1210/jcem.82.12.4408 · DOI · Paper page
- 10.1172/JCI118653 · DOI · Paper page
- Janik JE, 1997, J Clin Endocrinol Metab, 82, 3084
- 10.1016/S0026-0495(97)90059-7 · DOI
- Saad MF, 1997, J Clin Endocrinol Metab, 82, 579
- Ostlund RE, 1996, J Clin Endocrinol Metab, 81, 3909
- Rosenbaum M, 1996, J Clin Endocrinol Metab, 81, 3424
- 10.1677/joe.0.1540285 · DOI · Paper page
- 10.1074/jbc.270.48.28887 · DOI
- 10.1073/pnas.93.11.5507 · DOI
- 10.1210/endo.139.3.5792 · DOI
- 10.1172/JCI1411 · DOI · Paper page
- 10.1073/pnas.93.12.5793 · DOI · Paper page
- 10.1172/JCI118860 · DOI · Paper page
- 10.2337/diab.45.9.1276 · DOI
- Mantzoros CS, 1997, J Clin Endocrinol Metab, 82, 1687
- 10.1073/pnas.95.5.2541 · DOI · Paper page
- 10.1172/JCI118551 · DOI · Paper page
- 10.1006/bbrc.1996.1724 · DOI
- 10.1074/jbc.272.10.6093 · DOI · Paper page
- 10.1210/endo.137.11.8895313 · DOI
- 10.1038/381745a0 · DOI
- 10.1073/pnas.95.2.741 · DOI · Paper page
- 10.1111/j.1753-4887.1997.tb01602.x · DOI
- 10.1073/pnas.94.3.1023 · DOI · Paper page
- 10.1056/NEJM199706193362507 · DOI · Paper page
- 10.1056/NEJM199602013340511 · DOI
- 10.1097/00001756-199703240-00014 · DOI
- 10.1016/S0092-8674(00)80937-X · DOI · Paper page
- 10.1038/sj.mp.4000497 · DOI
- 10.2337/diab.47.2.294 · DOI · Paper page
- 10.1038/29993 · DOI · Paper page
- 10.1016/S0092-8674(00)81104-6 · DOI · Paper page
- 10.1055/s-2007-979891 · DOI
- 10.1006/bbrc.1996.6030 · DOI
- Cumin F, 1996, Int J Obes Relat Metab Disord, 20, 1120
- 10.1172/JCI119125 · DOI · Paper page
- 10.1006/bbrc.1996.0328 · DOI
- 10.1016/S0140-6736(96)03173-X · DOI · Paper page
- 10.2337/diab.46.8.1360 · DOI · Paper page
- 10.1016/S0140-6736(97)06348-4 · DOI · Paper page
- 10.2337/diab.45.11.1638 · DOI
- 10.1172/JCI118913 · DOI · Paper page
- 10.1210/jcem.82.5.4063 · DOI · Paper page
- 10.2337/diab.46.5.917 · DOI
- 10.1007/BF02002918 · DOI
- 10.1210/jcem.82.5.3935 · DOI · Paper page
- 10.1210/endo.138.5.5238 · DOI · Paper page
- 10.1016/S0960-9822(02)70684-2 · DOI · Paper page
- 10.1182/blood.V89.5.1507 · DOI
- 10.1210/jcem.82.12.4590 · DOI · Paper page
- 10.1126/science.274.5292.1466c · DOI
- 10.1210/jcem.83.4.4798 · DOI
- Garcia-Mayor RV, 1997, J Clin Endocrinol Metab, 82, 2849
- Mantzoros CS, 1997, J Clin Endocrinol Metab, 82, 1066
- 10.1038/43185 · DOI · Paper page
- 10.2337/diab.45.5.679 · DOI
- 10.2337/diab.45.5.675 · DOI
- 10.1172/JCI118007 · DOI · Paper page
- 10.1006/bbrc.1996.0473 · DOI
- 10.2337/diab.45.5.687 · DOI
- 10.2337/diab.45.5.691 · DOI
- 10.1016/S0092-8674(00)81294-5 · DOI · Paper page
- 10.1038/509 · DOI · Paper page
- 10.2337/diab.46.4.717 · DOI · Paper page
- 10.1055/s-2007-979883 · DOI
- 10.1210/endo.137.4.8625930 · DOI
- 10.1038/382250a0 · DOI · Paper page
- 10.1210/endo.138.6.5209 · DOI · Paper page
- 10.2337/diab.46.12.2040 · DOI · Paper page
- Mantzoros CS, 1995, Adv Endocrinol Metab, 6, 193
- 10.1210/endo.138.8.5327 · DOI · Paper page
- 10.2337/diab.45.7.988 · DOI · Paper page
- 10.1093/humrep/12.4.633 · DOI
- 10.1046/j.1365-2265.1997.1200936.x · DOI
- Laughlin GA, 1997, J Clin Endocrinol Metab, 82, 1692
- 10.1210/jcem.82.6.3996 · DOI
- Brzechffa PR, 1996, J Clin Endocrinol Metab, 81, 4166
- Karlsson C, 1997, J Clin Endocrinol Metab, 82, 4144
- 10.1210/endo.138.8.5311 · DOI · Paper page
- 10.1210/endo.138.2.5035 · DOI · Paper page
- Grinspoon S, 1996, J Clin Endocrinol Metab, 81, 3861
- 10.1046/j.1365-2265.1997.1260938.x · DOI
- 10.1055/s-2007-979885 · DOI
- 10.1038/sj.mp.4000282 · DOI
- Mantzoros CS, 1997, J Clin Endocrinol Metab, 82, 1845
- 10.1038/sj.mp.4000323 · DOI
- 10.1038/sj.mp.4000418 · DOI
- Merabet E, 1997, J Clin Endocrinol Metab, 82, 847
- Mantzoros CS, 1997, J Clin Endocrinol Metab, 82, 497
- 10.1006/bbrc.1997.6378 · DOI
- Valcavi R, 1997, J Clin Endocrinol Metab, 82, 1632
- Grunfeld C, 1996, J Clin Endocrinol Metab, 81, 4342
- 10.1016/S0026-0495(97)90258-4 · DOI
- 10.1055/s-2007-979886 · DOI
- 10.1073/pnas.94.16.8878 · DOI · Paper page
- 10.1074/jbc.272.39.24129 · DOI · Paper page
- 10.2337/diab.47.2.230 · DOI
- 10.1006/cyto.1996.0104 · DOI
- 10.1073/pnas.94.12.6456 · DOI
Cited by
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
Self-citationLeptin and Obesity: Role and clinical implication.
Obradovic, M., Sudar-Milovanovic, E., Soskic, S., Essack, M., Arya, S., Stewart, A. J., Gojobori, T., & Isenovic, E. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.585887 · Cited by 1,121
Tomiyama, A. J. (2019) · Annual Review of Psychology · doi:10.1146/annurev-psych-010418-102936 · Cited by 695
Leptin in Human Physiology and Pathophysiology
Mantzoros, C. S., Magkos, F., Brinkoetter, M., Sienkiewicz, E., Dardeno, T. A., Kim, S.-Y., Hamnvik, O.-P. R., & Koniaris, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00315.2011 · Cited by 593
Self-citationChan, J. L., Heist, K., DePaoli, A. M., Veldhuis, J. D., & Mantzoros, C. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17490 · Cited by 697
Self-citation
Metadata
- Authors
- Mantzoros, C. S.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1999-04-20
- Volume
- 130
- Issue
- 8
- Pages
- 671-680
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1968805253
- Cited by
- 584
- References
- 16
- FWCI
- 13.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence. https://app.cochat.ai/papers/10.7326/0003-4819-130-8-199904200-00014
- The paper
- Mantzoros, C. S. (1999). The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-130-8-199904200-00014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
